Article abstract


Nature Neuroscience 12, 829 - 838 (2009)
Published online: 7 June 2009 | doi:10.1038/nn.2333

HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the bold beta-catenin–TCF interaction

Feng Ye1,2, Ying Chen1, ThaoNguyen Hoang1, Rusty L Montgomery3, Xian-hui Zhao1, Hong Bu2, Tom Hu1, Makoto M Taketo4, Johan H van Es5, Hans Clevers5, Jenny Hsieh3, Rhonda Bassel-Duby3, Eric N Olson3 & Q Richard Lu1,3,6


Oligodendrocyte development is regulated by the interaction of repressors and activators in a complex transcriptional network. We found that two histone-modifying enzymes, HDAC1 and HDAC2, were required for oligodendrocyte formation. Genetic deletion of both Hdac1 and Hdac2 in oligodendrocyte lineage cells resulted in stabilization and nuclear translocation of beta-catenin, which negatively regulates oligodendrocyte development by repressing Olig2 expression. We further identified the oligodendrocyte-restricted transcription factor TCF7L2/TCF4 as a bipartite co-effector of beta-catenin for regulating oligodendrocyte differentiation. Targeted disruption of Tcf7l2 in mice led to severe defects in oligodendrocyte maturation, whereas expression of its dominant-repressive form promoted precocious oligodendrocyte specification in developing chick neural tube. Transcriptional co-repressors HDAC1 and HDAC2 compete with beta-catenin for TCF7L2 interaction to regulate downstream genes involved in oligodendrocyte differentiation. Thus, crosstalk between HDAC1/2 and the canonical Wnt signaling pathway mediated by TCF7L2 serves as a regulatory mechanism for oligodendrocyte differentiation.

Top
  1. Department of Developmental Biology and Kent Waldrep Foundation Center for Basic Neuroscience Research on Nerve Growth and Regeneration, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  2. Laboratory of Transplant Engineering and Immunology, West China Hospital, Sichuan University, China.
  3. Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  4. Department of Pharmacology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  5. Hubrecht Institute, Utrecht, The Netherlands.
  6. West China Second University Hospital, Sichuan University, China.

Correspondence to: Q Richard Lu1,3,6 e-mail: qrichard.lu@utsouthwestern.edu



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.


Extra navigation

Subscribe to Nature Neuroscience

Subscribe

Open Innovation Challenges

naturejobs

ADVERTISEMENT